PEDIATRICS Vol. 83 No. 2 February 1989, pp. 256-261
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGregor, R. S.
Right arrow Articles by Gartner, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGregor, R. S.
Right arrow Articles by Gartner, J. C., Jr

Varicella in Pediatric Orthotopic Liver Transplant Recipients

Robert S. McGregor MD1, Basil J. Zitelli MD1, Andrew H. Urbach MD1, J. Jeffrey Malatack MD1, and J. Carlton Gartner Jr MD1

1 The Department of Pediatrics, Children's Hospital of Pittsburgh

From May 1981 to May 1984, 90 pediatric patients underwent liver transplantation and 65 patients survived as of May 1986. Two of the nonsurvivors died with complications related to clinical varicella. Of these 67 patients (65 survivors and two nonsurvivors who died of varicella-related causes), 51 patients were determined to be varicella susceptible. Clinical disease developed in no patients with serologic evidence or clinical history of varicella prior to transplantation. Eighteen susceptible patients were exposed and received zoster immune globulin and varicella did not develop. Clinical disease developed in eight patients despite zoster immune globulin, although one patient received it 96 hours after exposure. Six patients received no zoster immune globulin and clinical varicella developed. In all, varicella developed in 14 patients. Thirteen were admitted to the hospital and treated with intravenous acyclovir. Of those treated, two died of causes related to complications of varicella. The remaining patients treated with acyclovir had mild disease. The one patient not treated with acyclovir also had mild disease. We conclude that patients contracting varicella after liver transplantation while receiving maintenance immunosuppressive agents should be treated with intravenous acyclovir. Generally, when treated with acyclovir while receiving maintenance immunosuppressive drugs, these patients have mild clinical disease. Patients recently treated with high-dose prednisone and cyclosporine may have severe clinical disease resulting in death.

Key Words: varicella • liver transplantation • acyclovir

Submitted on December 30, 1987
Accepted on February 23, 1988




This article has been cited by other articles:


Home page
 CVIHome page
F. J. Jenkins, D. T. Rowe, and C. R. Rinaldo Jr.
Herpesvirus Infections in Organ Transplant Recipients
Clin. Vaccine Immunol., January 1, 2003; 10(1): 1 - 7.
[Full Text] [PDF]

Home page
 PediatricsHome page
M. Broyer, M. J. Tete, G. Guest, M. F. Gagnadoux, and C. Rouzioux
Varicella and Zoster in Children After Kidney Transplantation: Long-term Results of Vaccination
Pediatrics, January 1, 1997; 99(1): 35 - 39.
[Abstract] [Full Text] [PDF]